Gladys Nunez

Gladys Nunez is a prominent figure in the biotechnology and venture capital industry, currently serving as the Director of Amgen Ventures, the corporate venture arm of Amgen.1 Here's a comprehensive overview of her background and accomplishments:

Professional Experience

Gladys Nunez joined Amgen in 1997 and has held various roles within the company over the years.1 Her career at Amgen includes:

• Director of Amgen Ventures (current role)
• Senior Manager for Technology Licensing
• Research Scientist
• Quality Control Scientist
• Bioscientist

Prior to her current position, Nunez spent 12 years in Amgen's External R&D group, where she was responsible for prospecting and negotiating external alliances.1

Responsibilities at Amgen Ventures

As Director of Amgen Ventures, Nunez:

• Leads investment diligence and strategy for Amgen's corporate venture group
• Manages the R&D Seed Fund
• Serves as a board observer for several portfolio companies, including Obsidian Therapeutics, Kernal Bio, Immunoscape, Feldan Therapeutics, and Celsius1

Education

Nunez holds impressive academic credentials:

• MSc in Biochemical Pharmacology from the University of Southampton, England
• BSc in Pre-Med from Marist College1

Additional Roles and Contributions

Beyond her primary responsibilities at Amgen, Gladys Nunez is actively involved in the biotech community:

• Member of the site senior leadership team at Amgen's Cambridge, MA location
• Supports local outreach and startup network strategy
• Board member and treasurer of Latinos in Bio, a non-profit organization empowering Latinx professionals in the life science industry
• Member of the Healthcare Businesswomen's Association, supporting women's entrepreneurial development and increasing the presence of women in venture capital careers1

Investment Focus

At Amgen Ventures, Nunez manages a significant investment portfolio:

• Oversees $625 million in funds
• Has made more than 70 investments
• Typical investment range: $2.0M - $10.0M, with a sweet spot of $6.0M23

Gladys Nunez's extensive experience in both scientific research and business development, combined with her leadership in venture capital, makes her a valuable asset in the biotechnology industry. Her work not only drives innovation through strategic investments but also promotes diversity and inclusion in the life sciences sector.